Zolmitriptan Tablet, Film Coated
Product Images NDC 16571-804

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 16571-804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Zolmitriptan Fig1)

A line graph titled 'Estimated Probability of Achieving Initial Headache Response' shows the reduction in headache severity over time up to 4 hours after dose. The x-axis represents time from initial dose (0 to 4 hours), and the y-axis shows the estimated probability of response (0% to 100%). Four lines compare placebo and Zolmitriptan doses of 1 mg, 2.5 mg, and 5 mg, with higher doses showing greater probability of headache response over time.*

FDA Label Image

Figure 2 (Zolmitriptan Fig2)

Line graph showing the estimated probability of medication or rescue over 24 hours from the initial dose, with separate curves for placebo, 1 mg, 2.5 mg, and 5 mg doses. The y-axis represents the probability ranging from 0% to 100%, and the x-axis represents time in hours from 0 to 24.*

FDA Label Image

Package Label.principal Display Panel (2.5 mg Blister Carton)

Packaging label for Zolmitriptan Tablets USP 2.5 mg film-coated tablets by Rising Pharma Holdings, Inc. The label shows the product name, strength (2.5 mg), dosage form, and package size of 6 unit-dose tablets (1 x 6). It includes the NDC number 16571-803-16 and indicates the product is Rx only. The label also states the product is distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ, and made in India.*

FDA Label Image

Package Label.principal Display Panel (5 mg Blister Carton)

Zolmitriptan Tablets, USP 5 mg film-coated unit-dose tablets packaging label from Rising Pharma Holdings, Inc. The label shows the product name and strength, dosage form as tablets, package size of 3 (1x3) unit-dose tablets, with NDC 16571-804-13. The label indicates the tablets are prescription only (Rx only) and includes distribution information stating the product is made in India and distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ.*

FDA Label Image

Zolmitriptan Chemical Structure (Zolmitriptan Str1)

Chemical structure of zolmitriptan, depicted as a molecular diagram showing its detailed atomic bonds and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.